(ZLAB) – FDA
-
Bristol-Myers Squibb (BMY) Announces KRYSTAL-12 Confirmatory Trial of KRAZATI Meets Primary Endpoint
-
Zai Lab (ZLAB) Partner Novocure (NVCR) Announces METIS Phase 3 Clinical Trial Met Primary Endpoint
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ZLAB Stock Lookup